Our policy in the Medical Programs Department of the National Psoriasis Foundation (NPF) is to ensure balance, independence, objectivity, and scientific rigor in all our educational programs. Anyone presenting or participating in the planning of any NPF CME programs is expected to disclose to the Medical Programs Department any real or apparent affiliation(s) within the past 12 months that may have a direct bearing on the subject matter of the continuing medical education program. The intent of this policy is to ensure continuing medical education programs that are free of commercial interests.
The Allied Healthcare Recognition Provider Program faculty and planning committee have disclosed the following relationships with commercial interests:
Paul Yamauchi, M.D., Ph.D
Advisory Board – Amgen, Dermira, Lilly ICOS LLC
Consultant – Abbvie, Amgen, Celgene, Janssen-Ortho, Leo, Novartis, Pfizer, Regeneron
Speaker – Abbvie, Amgen, Celgene, Galderma, Janssen-Ortho, Leo, Novartis
Principle Investigator – Amgen, Celgene, Dermira, Galderma, Janssen-Ortho, Leo, Lilly ICOS LLC, Medimmune, Novartis, Pfizer, Regeneron, Sandoz
Lakshi Aldredge, MSN, ANP-BC
Advisor – AbbVie, Celgene, Eli Lilly, Novartis
Speaker – AbbVie, Celgene, Eli-Lilly, Novartis
Consultant – AbbVie, Celgene, Eli Lilly, Novartis
Planning Committee: Susan Hardin, and Nicole Ramos have disclosed no relevant financial interests with any commercial interests.